Report for: Hematopoietic stem cell transplantation for people with sickle cell disease

Title	Hematopoietic stem cell transplantation for people with sickle cell disease
Published by	John Wiley & Sons, Ltd, May 2013
DOI	10.1002/14651858.cd007001.pub3
Pubmed ID	23728664
Authors	Oringanje, Chioma, Nemecek, Eneida, Oniyangi, Oluseyi
Abstract	Sickle cell disease is a genetic disorder involving a defect in the red blood cells due to its sickled hemoglobin. The main therapeutic interventions include preventive and supportive measures. Hematopoietic stem cell transplantations are carried out with the aim of replacing the defective cells and their progenitors (hematopoietic (i.e. blood forming) stem cells) in order to correct the disorder.

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
Unknown	1	100%

Type	Count	As %
Members of the public	1	100%

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Country	Count	As %
Unknown	35	100%

Readers by professional status	Count	As %
Student > Bachelor	8	23%
Researcher	7	20%
Student > Ph. D. Student	4	11%
Lecturer	2	6%
Other	2	6%
Other	4	11%
Unknown	8	23%

Readers by discipline	Count	As %
Medicine and Dentistry	6	17%
Biochemistry, Genetics and Molecular Biology	4	11%
Agricultural and Biological Sciences	3	9%
Psychology	2	6%
Engineering	2	6%
Other	6	17%
Unknown	12	34%

Hematopoietic stem cell transplantation for people with sickle cell disease